Appointment of statutory auditor of the company subject to approval of shareholders at ensuing AGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd's board, at a meeting held on September 2, 2025, approved the appointment of M/s. Bilimoria Mehta & Co., Chartered Accountants (FRN: 101490W) as the new statutory auditor for a 5-year term covering FY 2025-26 to FY 2029-30. This change is a routine rotation after the current auditor M/s. Abhishek S Tiwari & Associates completes its 5-year tenure at the conclusion of the upcoming 33rd AGM. The board also fixed the 33rd AGM for September 29, 2025 (via video conferencing), approved the Annual Report for FY 2024-25, approved a revision in remuneration of Whole Time Director & CFO Mr. Sohan Chaturvedi effective October 1, 2025, and recommended material related party transactions for shareholder approval.
The auditor change is a routine end-of-term rotation with no governance red flags. Shareholders should note the upcoming AGM on September 29, 2025 where they will vote on the new auditor appointment, CFO remuneration revision, and related party transactions. These are standard AGM business items with no material adverse implications for shareholders.